Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Short term Debt (2020 - 2025)

Historic Short term Debt for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $32.6 million.

  • MDxHealth's Short term Debt rose 2576.45% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 2576.45%. This contributed to the annual value of $26.4 million for FY2024, which is 81229.71% up from last year.
  • As of Q3 2025, MDxHealth's Short term Debt stood at $32.6 million, which was up 2576.45% from $75.7 billion recorded in Q2 2025.
  • MDxHealth's Short term Debt's 5-year high stood at $75.7 billion during Q2 2025, with a 5-year trough of $412000.0 in Q2 2022.
  • In the last 5 years, MDxHealth's Short term Debt had a median value of $14.3 million in 2021 and averaged $5.4 billion.
  • Its Short term Debt has fluctuated over the past 5 years, first plummeted by 4760.19% in 2022, then skyrocketed by 30377195.24% in 2025.
  • Quarter analysis of 5 years shows MDxHealth's Short term Debt stood at $4.4 million in 2021, then plummeted by 47.6% to $2.3 million in 2022, then increased by 24.41% to $2.9 million in 2023, then soared by 812.3% to $26.4 million in 2024, then increased by 23.33% to $32.6 million in 2025.
  • Its Short term Debt stands at $32.6 million for Q3 2025, versus $75.7 billion for Q2 2025 and $27.6 million for Q1 2025.